Displaying 29 Tests
48120
Serum

Useful for determination of infection with Human Immunodeficiency Virus (HIV).

Serum

SST (1)



None

None



REFRIGERATE (7 Days)



87389

Acquired Immune Deficiency Syndrome (AIDS), HIV (Human Immunodeficiency Virus), Anti-HIV

Useful for serologic detection of recent or past parvovirus B19 infection.

Serum

SST (1)



None

None



REFRIGERATE (3 Days)

6 Days

Enzyme Immunoassay

86747 x2

B19, Erythrovirus B19, Fifth Disease, Human Parvovirus, Slapped Cheek Disease

Useful for detection of drug abuse involving phencyclidine (angel dust).

Urine

Sterile Container (1)



None

None



REFRIGERATE (14 Days)

4 Days

Gas Chromatography/Mass Spectrometry (GC/MS)

83992

Angel Dust, Phencyclidine, PCP, Rocket Fuel, Super Weed, TCP, Killer Weed

Useful for monitoring for appropriate therapeutic concentration of phenobarbital and/or assessing compliance or toxicity.

Serum

Red (1)



None

None



REFRIGERATE (14 Days)

4 Days

High Performance Liquid Chromatography

80184

Barbita, Luminal, PBR, Solfoton
48141
Serum

Useful to monitor for appropriate therapeutic concentration and/or assessing compliance or toxicity.

Serum

Red (1)



None

None



REFRIGERATE (14 Days)

4 Days

High Performance Liquid Chromatography

80185

DPH, Dilantin, Diphenylhydantoin, Phenytoin

Monitoring for appropriate therapeutic concentration of free phenytoin and/or assessing compliance and toxicity. Free phenytoin level is the best indicator of adequate therapy in renal failure.

Serum

Red (1)



None

None



REFRIGERATE (14 Days)

2 Days

Homogenous Enzyme Immunoassay

80186

Dilantin Free, Free Dilantin, Free Phenytoin
48142
Serum

Phosphorus levels may be used in the diagnosis and management of a variety of disorders including bone, parathyroid and renal disease

Serum

SST (1)



Plasma

Green (1)



REFRIGERATE (4 Days)


Phosphomolybdate

84100

Phosphate, PO4, Phos
48195
Whole Blood

Provides a platelet count to diagnose clotting and coagulation disorders such as thrombocytopenia and thrombocytosis.

Whole Blood

EDTA (1)



None

None



REFRIGERATE (48 Hours)


Photometry and hemoglobinometry

85049

Platelets
48250
Serum

Potassium should be monitored during treatment of many conditions but especially in diabetic ketoacidosis and any intravenous therapy for fluid replacement. Used in the evaluation of electrolyte balance, cardiac arrythmia, muscular weakness, hepatic encephalopathy, and renal failure.

Serum

SST (1)



Plasma

Green (1) Lithium Heparin



REFRIGERATE (7 Days)


Ion-selective electrode diluted (indirect)

84132

K

Useful for assessing nutritional status, especially in monitoring the response to nutritional support in an acutely ill patient.

Serum

SST (1)



Plasma

Green (1)



REFRIGERATE (7 Days)

4 Days

REF (7 Days)

84134

PAB, TBPA, Transthyretin
48244
Serum

Used as an ancillary test for congenital adrenal hyperplasia, particularly in situations in which a diagnosis of 21-hydroxylase and 11-hydroxylase deficiency have been ruled out. Useful for confirming a diagnosis of 3-beta-hydroxy dehydrogenase deficiency.

Serum

Red (1)



None

None



FREEZE (30 Days) CRITICAL

9 Days

LC-Mass Spectrometry/Mass Spectrometry

84140
48361
Serum

Useful for assessing compliance, monitoring for appropriate levels or primidone, assessing toxicity.

Serum

Red (1)



None

None



REFRIGERATE (14 Days)

4 Days

High Performance Liquid Chromatography

80188

Mysoline
48662
Serum

Useful in the diagnosis of bacteremia and septicemia in adults and children (including neonates), the diagnosis of renal involvement in urinary tract infection in children, the diagnosis of bacterial infection in neutropenic patients, the diagnosis, risk stratification, and monitoring of septic shock, the diagnosis of systemic secondary infection post-surgery (and in severe trauma, burns, and multiorgan failure). Also useful in the differential diagnosis of bacterial versus viral meningitis, and community-acquired bacterial versus viral pneumonia. Also helpful for the monitoring of therapeutic response to antibacterial therapy.

Serum

SST (1)


2.0 mL

Plasma

Green - Lithium Heparin (2)

Allow specimen to clot for at least 15 minutes post-draw. Centrifuge and seperate serum from red cells within 2 hours of collection. Submit unopened tube refrigerated.

Must centrifuge within 2 hours of collection. The same specimen type (serum, plasma) should be used throughout the patient's clinical course.

REFRIGERATE (5 Days)

4 Days

Immunoassay

84145

Calcitonin, Procalc

An aid in monitoring antiresorptive and anabolic therapy in patients with osteoporosis. Useful in assessment of conditions associated with increased bone turnover such as Paget disease.

Serum

SST (1)



None

None



REFRIGERATE (27 Days)

9 Days

Immunoassay

83519
48144
Serum

Useful for evaluation of ovulation in a menstrual cycle, evaluation of placental function in pregnancy, and workup of patients with adrenal or testicular tumors.

Serum

SST (1)



Plasma

Green (1)



REFRIGERATE (7 Days)


CMIA

84144

PROG
48145
Serum

Useful for aiding in evaluation of pituitary tumors, amenorrhea, galactorrhea, infertility, and hypogonadism, and for monitoring of prolactin-producing tumors.

Serum

SST (1)



Plasma

Green (1)



REFRIGERATE (7 Days)


CMIA

84146

PRL

Useful for predicting recurrence after radical prostatectomy for clinically localized prostate cancer and following response to androgen ablation therapy, when used in conjunction with prostate-specific antigen.

Serum

SST (1)



None

None


Must obtain specimen before (or 48 hours post) rectal examination, biopsy, prostatectomy, or prostatic massage.

FREEZE (28 Days)

6 Days

Immunoassay

84066

PAP, Acid Phosphatase Prostatic Isoenzyme, Phosphatase

Useful as an initial test for evaluating patients suspected of having congenital protein C deficiency, including those with personal or family histories of thrombotic events, and for detecting and confirming congenital type I and type II protein C deficiencies. Also useful for detecting and confirming congenital homozygous protein C deficiency, and for identifying decreased functional protein C of acquired origin (eg, due to oral anticoagulant effect, vitamin K deficiency, liver disease, intravascular coagulation and fibrinolysis/disseminated intravascular coagulation).

Plasma

Lt. Blue (1)



None

None


Please note if PT is being treated with Coumadin. Spin x2 and freeze plasma within 4 hours of collection.

FREEZE (14 Days)

4 Days

Chromogenic

85303

Functional Protein C, TEST
48285
Plasma

Useful for differentiating congenital type I protein C deficiency from type II deficiency, for evaluating the significance of decreased functional protein C, especially when decreased protein C activity might be congenital rather than acquired (eg, due to oral anticoagulant effect, vitamin K deficiency, liver disease, or intravascular coagulation and fibrinolysis/disseminated intravascular coagulation). This test is not useful for predicting a thrombotic event.

Plasma

Lt. Blue (1)



None

None


CRITICAL FROZEN. SEND DEDICATED SAMPLE.

FREEZE (30 Days)

6 Days

Enzyme Immunoassay

85302

Protein C Immunologic

 
48327
Plasma

Useful for evaluating patients with a history of venous thromboembolism, and as a second-order testing for diagnosis of congenital or acquired protein S deficiency. For example, as an adjunct to initial testing based on results of protein S antigen assay (free protein S antigen, with or without total protein S antigen assay).

Plasma

Lt. Blue (1)



None

None


PT cannot be receiving Coumadin. Spin x2 and freeze plasma immediately.

FREEZE (14 Days)

8 Days

Optical Clot-Based

85306

Functional Protein S
48286
Plasma

Useful for investigation of patients with a history of thrombosis

Plasma

Lt. Blue (1)



None

None


CRITICAL FROZEN. SEND DEDICATED SAMPLE.

FREEZE (30 Days)

4 Days

Latex Immunoassay

85305

Protein S Immunologic

 

Direct mutation analysis for the prothrombin (PT) 20210A allele should be reserved for patients with clinically suspected thrombophilia. There may be additional indications for direct PT 20210A mutation testing, such as in determining the duration of anticoagulation therapy of venous thromboembolism patients and screening for women contemplating hormone therapy.

Whole Blood

EDTA (1)



None

None



RT (5 Days)

6 Days

Hologic invader Assay

81240

Factor II 20210 mutation, Prothrombin 20210 mutation, Prothrombin Nucleotide, PTNT
48537
Serum

Useful for assessing the risk of prostate cancer in patients with borderline or moderately increased total PSA (4.0-10.0 ng/mL) , and for determining which patients should have follow-up prostate biopsy.

Serum

SST



None

None


Avoid biotin (B7) for 12 HR prior to collection. Pour off serum within 3 hours of collection and freeze.

FREEZE (90 Days)

4 Days

Electrochemiluminescence Immunoassay (ECLIA)

84153, 84154

Free PSA, PSA Free/Total Ratio, PSA Total and Free, PSA Ratio
48146
Serum

Useful for monitoring patients with a history of prostate cancer, as an early indicator of recurrence, and for measuring response to treatment.

Serum

SST (1)



None

None


Pour off within 24 hours of collection and freeze serum.

FREEZE (7 Days)


CMIA

84153

PSA, SPSA, Total PSA, PSAD
48147
Serum

Useful for monitoring patients with a history of prostate cancer, as an early indicator of recurrence, and for measuring response to treatment.

Serum

SST (1)



None

None


Pour off within 24 hours of collection and freeze serum.

FREEZE (7 Days)


CMIA

G0103

PSA, SPSA, Total PSA, PSAS
48647
Serum

Ultra sensitive PSA, useful for close monitoring of patients with a history of prostate cancer, as an early indicator of recurrence, and for measuring response to treatment.

Serum

SST (1)



None

Red (1)


Collect specimen prior to or at least one week after biopsy, rectal exam, or ther manipulation of prostate. Pour off and freeze serum as soon as possible.

FREEZE (30 Days)

4 Days

Chemiluminescence

84153

Ultra Sensitive PSA, Prostate Specific Antigen Ultra Sensitive

 
48038
Plasma

Screening assay to detect deficiency of one or more coagulation factors or coagulation inhibition.

Plasma

Lt. Blue (1)



None

None


Tube MUST be filled to line for testing. Freeze within 4 hours of draw.

FREEZE (7 Days)


Coagulometric/Turbidimetric

85610

Prothrombin Time, PT-INR, INR, PT
48039
Plasma

Useful in evaluating a patient's ability to appropriately form blood clots, and to monitor the treatment effects of Heparin.

Plasma

Lt. Blue (1)



None

None


Tube MUST be filled to line for testing. Freeze within 4 hours of draw.

FREEZE (7 Days)


Coagulometric/Turbidimetric

85610, 85730

Activated Partial Thromboplastin Time
48148
Serum

Aides in the diagnosis of hypercalcemia, hyperparathyroidism, and hypoparathyroidism, and monitors end-stage renal failure for possible renal osteodystrophy.

Serum

SST (1)



Plasma

Green (1) Lithium Heparin



FREEZE (6 Months)


CMIA

83970

Intact PTH, Parathyroid Hormone